Then, to provide translational relevance to this finding, we performed a longer intervention (proportional to that which might be conducted in older adults), in which we treated both old and tauopathy model mice with NF-κB/NLRP3-targeting Nanoligomers for one month. The gene discussed is NFKB1; the disease is tauopathy.